J Paul Burnett, Jr

Title: J Paul Burnett, Jr: Innovator in Glutamate Receptor Research

Introduction

J Paul Burnett, Jr. is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of molecular biology, particularly in the study of glutamate receptors. With a total of 5 patents to his name, Burnett has established himself as a key figure in his area of expertise.

Latest Patents

Among his latest patents, one invention focuses on the excitatory amino acid receptor protein and related nucleic acid compounds. This invention describes a novel human glutamate receptor, designated HmGluR3. It encompasses nucleic acids encoding this receptor, or a fragment thereof, as well as methods employing this receptor and the nucleic acid compounds. Another significant patent involves human glutamate receptor proteins and associated DNA compounds. This invention provides a human glutamate receptor and related DNA compounds that are useful not only in assays for potential pharmaceuticals but also in various molecular biology techniques.

Career Highlights

J Paul Burnett, Jr. is currently associated with Eli Lilly and Company, where he continues to advance research in his field. His work has been instrumental in developing new methodologies and compounds that have the potential to impact pharmaceutical research and development.

Collaborations

Throughout his career, Burnett has collaborated with esteemed colleagues, including Nancy G Mayne and Robert L Sharp. These collaborations have further enriched his research and contributed to the advancement of knowledge in glutamate receptor studies.

Conclusion

J Paul Burnett, Jr. is a distinguished inventor whose work in glutamate receptor research has led to significant advancements in molecular biology. His contributions continue to influence the field and pave the way for future innovations.